Huntington’s Disease

Stereological Methods to Quantify Cell Loss in the Huntington’s Disease Human Brain.- Assessing Autophagic Activity and Aggregate Formation of Mutant Huntingtin in Mammalian Cells.- A Filter Retardation Assay Facilitates the Detection and Quantification of Heat-Stable, Amyloidogenic Mutant Huntingtin Aggregates in Complex Biosamples.- Cellular Models: HD Patient-Derived Pluripotent Stem Cells.- Non-Mammalian Models of Huntington’s Disease.- Mouse Models of Huntington’s Disease.- Motor Assessment in Huntington’s Disease Mice.- Automated Operant Assessments of Huntington’s Disease Mouse Models.- Neurophysiological Assessment of Huntington’s Disease Model Mice.- Murine Models of Huntington’s Disease for Evaluating Therapeutics.- Generating Excitotoxic Lesion Models of Huntington’s Disease.- Large-Brained Animal Models of Huntington’s Disease: Sheep.- Minipigs as Large-Brained Animal Model for Huntington’s Disease: From Behavior and Imaging to Gene Therapy.- Non-Human Primate Models of Huntington’s Disease and Their Application in Translational Research.- In Vivo Multidimensional Brain Imaging in Huntington’s Disease Animal Models.- Magnetic Resonance Imaging in Huntington’s Disease.- Biofluid Biomarkers in Huntington’s Disease.- Assessing and Modulating Kynurenine Pathway Dynamics in Huntington’s Disease: Focus on Kynurenine 3-Monooxygenase.- Assessing Mitochondrial Function in In Vitro and Ex Vivo Models of Huntington’s Disease.- Using Genomic Data to Find Disease-Modifying Loci in Huntington’s Disease (HD).-CRISPR/Cas9-Mediated Genome Editing for Huntington's Disease.- Methods for Assessing DNA Repair and Repeat Expansion in Huntington’s Disease.- Translating Antisense Technology into a Treatment for Huntington’s Disease.- Disease Modification through Trophic Factor Delivery.- Methods to Quantify Cell Signaling and GPCR Receptor Ligand Bias: Characterization of Drugs that Target the Endocannabinoid Receptors in Huntington’s Disease.- Dissection and Preparation of Human Primary Fetal Ganglionic Eminence Tissue for Research and Clinical Application.- Robust Induction of DARPP32-Expressing GABAergic Striatal Neurons from Human Pluripotent Stem Cells.- Quality Assessment and Production of Human Cells for Clinical Use.